Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
Harms PW, Hovelson DH, Cani AK, Omata K, Haller MJ, Wang ML, Arps D, Patel RM, Fullen DR, Wang M, Siddiqui J, Andea A, Tomlins SA.
Harms PW, et al. Among authors: arps d.
Hum Pathol. 2016 May;51:25-31. doi: 10.1016/j.humpath.2015.12.015. Epub 2016 Jan 7.
Hum Pathol. 2016.
PMID: 27067779